We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XBIT market cap is 208.2M. The company's latest EPS is USD -1.0793 and P/E is -6.35.
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 500k | 1.53M | 1.68M | 300k | 0 |
| Operating Income | -7.55M | -11.87M | -6.26M | -7.77M | -6.78M |
| Net Income | -5.4M | -11.64M | -12.66M | -3.2M | -3.82M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.43M | 0 | 44M | 18.39M | 4.01M |
| Operating Income | -20.22M | -29.53M | -15.6M | -23.61M | -33.46M |
| Net Income | -21.14M | 668.63M | -11.22M | -17.41M | -32.9M |
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 270.8M | 266.46M | 250.83M | 246.1M | 242.12M |
| Total Liabilities | 5.24M | 10.67M | 6.03M | 5.7M | 5.22M |
| Total Equity | 265.56M | 255.8M | 244.81M | 240.4M | 236.91M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.35M | 816.88M | 353.74M | 275.18M | 246.1M |
| Total Liabilities | 2.95M | 61.25M | 5.11M | 5.79M | 5.7M |
| Total Equity | 41.4M | 755.63M | 348.64M | 269.39M | 240.4M |
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.12M | -11.5M | -17.53M | -14.82M | -4.81M |
| Investing | -161k | -243k | -59.99M | -63.89M | -6k |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.54M | -18.27M | -65.15M | 69.45M | -14.82M |
| Investing | -122k | 674.8M | -3.73M | -3.53M | -63.89M |
| Financing | 513k | 42.1M | -409.72M | -67.01M | N/A |
| Market Cap | 208.2M |
| Price to Earnings Ratio | -6.35 |
| Price to Sales Ratio | 52.09 |
| Price to Cash Ratio | 1.33 |
| Price to Book Ratio | 0.87 |
| Dividend Yield | - |
| Shares Outstanding | 30.48M |
| Average Volume (1 week) | 49.3k |
| Average Volume (1 Month) | 54.55k |
| 52 Week Change | 84.59% |
| 52 Week High | 9.96 |
| 52 Week Low | 3.51 |
| Spread (Intraday) | 1.17 (15.6%) |
| Company Name | XBiotech Inc |
| Address |
5217 winnebago ln, austin, tx 78744 austin, texas 78744 |
| Website | https://www.xbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
